Preview

Cardiovascular Therapy and Prevention

Advanced search

Biobanking in the hospital of a multidisciplinary research medical center as a potential for a wide research range. Part I. Organizational and methodological aspects

https://doi.org/10.15829/1728-8800-2023-3749

Abstract

Aim. To develop an algorithm and manage total biobanking of samples of whole blood, serum and plasma of patients in the hospital of the National Medical Research Center for Therapy and Preventive Medicine in order to create a detailed biosample collection through the integration of electronic medical records and a biobank database.

Material and methods. The study includes all patients admitted to the hospital of the National Medical Research Center for Therapy and Preventive Medicine in various departments who signed informed consent for biobanking. Clinical information is collected as part of patient examination and stored in electronic medical records in the Medialog medical information system. Biobanking of blood and related products is carried out in accordance with standard operating procedures. From each patient, 12 aliquots of serum and blood plasma are stored, as well as 1 tube of whole blood with ethylenediaminetetraacetic acid potassium salt. Information about biospecimens, patient identification numbers and storage location coordinates are contained in the biobank database.

Results. An algorithm for total biobanking of biomaterial and data from inpatients has been developed and put into practice. This collection is associated with large biomedical data stored in a medical information system, laboratory information system and biobank. The combined databases make it possible to search for samples in the collection according to specified criteria.

Conclusion. The collection developed can be used for a wide range of studies by forming patient samples according to the necessary criteria. The developed algorithm for total biobanking in a hospital can be used in various medical centers equipped with biobanks.

About the Authors

A. I. Borisova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



O. V. Kopylova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



M. S. Pokrovskaya
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



I. A. Efimova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



A. V. Pustelenin
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



А. I. Ershova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow



References

1. Swede H, Stone C, Norwood A. National population­ based biobanks for genetic research. Genet Med. 2007;9:141­9. doi:10.1097/GIM.0b013e3180330039.

2. Al Kuwari H, Al Thani A, Al Marri A, et al. The Qatar Biobank: background and methods. BMC Public Health. 2015;15:1208. doi:10.1186/s12889­015­2522­7.

3. Al Thani A, Fthenou E, Paparrodopoulos S, et al. Qatar Biobank Cohort Study: Study Design and First Results. Am J Epidemiol. 2019;188(8):1420­33. doi:10.1093/aje/kwz084.

4. Sudlow C, Gallacher J, Allen N, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;31;12(3):e1001779. doi:10.1371/journal.pmed.1001779.

5. Leitsalu L, Haller T, Esko T, et al. Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu. Int J Epidemiol. 2015;44(4):1137­47. doi:10.1093/ije/dyt268.

6. McDavid A, Crane PK, Newton KM, et al. Enhancing the power of genetic association studies through the use of silver standard cases derived from electronic medical records. PLoS One. 2013;10;8(6):e63481. doi:10.1371/journal.pone.0063481.

7. Macheiner T, Huppertz B, Sargsyan K. Biobanking. Nachhaltige Nutzung biologischer Ressourcen am Beispiel der Biobank Graz [Biobanking. Sustainable use of biological resources on the example of the Biobank Graz]. Pathologe. 2013;34(4):366­9. German. doi:10.1007/s00292­013­1752­7.

8. Kopylova OV, Ershova AI, Pokrovskaya MS, et al. Population­ nosological research biobank of the National Medical Research Center for Therapy and Preventive medicine: analysis of biosamples, principles of collecting and storing information. Cardiovascular Therapy and Prevention. 2021;20(8):3119. (In Russ.) doi:10.15829/1728­88002021­3119.

9. Drapkina OM, Shalnova SA, Imaeva AE, et al. Epidemiology of cardiovascular diseases in regions of Russian Federation. Third survey (ESSE­RF­3). Rationale and study design. Cardiovascular Therapy and Prevention. 2022;21(5):3246. (In Russ.) doi:10.15829/1728­8800­2022­3246.

10. Pokrovskaya MS, Borisova AL, Metelskaya VA, et al. Role of biobanking in managing large­ scale epidemiological studies. Cardiovascular Therapy and Prevention. 2021;20(5):2958. (In Russ.). doi:10.15829/17288800­2021­2958.

11. Pokrovskaya MS, Sivakova OV, Meshkov AN, et al. Organization of biobanking of biological samples within the second stage of epidemiological study of cardiovascular risk factors and diseases in the regions of the Russian Federation (ESSERF2). Profilakticheskaya medicina. 2018;21(2­2):44­5. (In Russ.)

12. Pokrovskaya MS, Borisova AL, Kondratskaya VA, et al. Approaches to automation of the preanalytical phase of large­ scale research in the biobank of the National Medical Research Center for Therapy and Preventive Medicine of the Ministry of Health of Russia. Cardiovascular Therapy and Prevention. 2022;21(11):3404. (In Russ.) doi:10.15829/1728­8800­2022­3404.

13. Kopylova OV, Ershova AI, Efimova IA, et al. Electronic medical records and biobanking. Cardiovascular Therapy and Prevention. 2022;21(11):3425. (In Russ.) doi:10.15829/1728­8800­2022­3425.

14. Bryzgalina EV, Glotov AS. Ethical aspects of biobanking. In: Biobanking. National guidelines. Moscow: Triumph, 2022. p. 132153. (In Russ.) ISBN 978­5­93673­322­2.

15. Bledsoe MJ. Ethical Legal and Social Issues of Biobanking: Past, Present, and Future. Biopreserv Biobank. 2017;15(2):142­7. doi:10.1089/bio.2017.0030.

16. Pokrovskaya MS, Kondratskaya VA, Efimova IA. Features of biobanking and quality control of biological fluid samples. Blood, serum, plasma. In: Biobanking. National guidelines. Moscow: Triumph, 2022. p. 185­207. (In Russ.) ISBN: 978­5­93673­322­2.

17. Mooser V, Currat C. The Lausanne Institutional Biobank: a new resource to catalyse research in personalised medicine and pharmaceutical sciences. Swiss Med Wkly. 2014;4(144):w14033. doi:10.4414/smw.2014.14033.

18. Bernasconi L, Şen S, Angerame L, et al. Legal and ethical framework for global health information and biospecimen exchange — an international perspective. BMC Med Ethics. 2020;21(1):8. doi:10.1186/s12910­020­0448­9.

19. Lecaros JA. Biobanks for Biomedical Research: Evolution and Future. In: Valdés E, Lecaros JA (eds). Handbook of Bioethical Decisions. 2023;Vol.I. Collaborative Bioethics, vol 2. Springer, Cham. doi:10.1007/978­3­031­29451­8_17.


Supplementary files

What is already known about the subject?

  • The high significance of biospecimen collections in biobanks is due to the biomedical data associated with them.
  • Large-scale collections of biosamples collected from patients in a multidisciplinary hospital can be used for a wide research range due to the ability to form samples according to the necessary criteria.

What might this study add?

  • An algorithm has been developed for collecting high-quality samples of whole blood, serum and blood plasma from patients in a multidisciplinary hospital using the total biobanking method to create a collection of biospecimens, described in detail through the integration of electronic medical records (clinical data) and a biobank database (data on biospecimens).

Review

For citations:


Borisova A.I., Kopylova O.V., Pokrovskaya M.S., Efimova I.A., Pustelenin A.V., Ershova А.I., Drapkina O.M. Biobanking in the hospital of a multidisciplinary research medical center as a potential for a wide research range. Part I. Organizational and methodological aspects. Cardiovascular Therapy and Prevention. 2023;22(11):3749. (In Russ.) https://doi.org/10.15829/1728-8800-2023-3749

Views: 531


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)